Hantech Bio-Technology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	139.05	155.67	148.12	47.47	32.56
Depreciation & Amortization	38.17	30.35	19.44	18.86	18.24
Other Amortization	-	1.72	1.5	0.47	0.46
Loss (Gain) From Sale of Assets	-	0.35	0.11	0.55	0
Asset Writedown & Restructuring Costs	3.27	-	-	-	-
Loss (Gain) From Sale of Investments	0.74	-	-	-	-
Stock-Based Compensation	0.11	1.03	0.05	0.17	4.22
Provision & Write-off of Bad Debts	0.57	-0.03	-0.56	0.61	-1.05
Other Operating Activities	-4.77	-7.07	20.99	7.75	-14.59
Change in Accounts Receivable	-53.94	7.94	-37.82	-25.73	6.81
Change in Inventory	-48.32	13.76	-50.08	-9.72	1.46
Change in Accounts Payable	69.36	-52.85	65.47	20.05	-2.73
Change in Other Net Operating Assets	16.39	-0.13	24.68	2.69	-0.98
Operating Cash Flow	160.63	150.75	191.91	63.18	44.39
Operating Cash Flow Growth	6.55%	-21.44%	203.76%	42.33%	-59.95%
Capital Expenditures	-15.45	-24.63	-293.94	-82.88	-79.26
Sale of Property, Plant & Equipment	-	-	1.83	0.11	-
Sale (Purchase) of Intangibles	-1.27	-0.76	-3.28	-0.74	-1.06
Investment in Securities	-90.72	-	-1.2	-	-
Other Investing Activities	0.03	0.01	0.96	-0.57	0.56
Investing Cash Flow	-107.4	-25.38	-295.63	-84.07	-79.76
Short-Term Debt Issued	5	5	9	10	4
Long-Term Debt Issued	-	42.21	269.32	26.34	55.53
Total Debt Issued	5	47.21	278.32	36.34	59.53
Short-Term Debt Repaid	-5	-5	-10	-13	-
Long-Term Debt Repaid	-58.5	-215.44	-57.72	-58.45	-14.24
Total Debt Repaid	-63.5	-220.44	-67.72	-71.45	-14.24
Net Debt Issued (Repaid)	-58.5	-173.23	210.6	-35.11	45.29
Issuance of Common Stock	29.08	282.4	2.07	44.63	3.17
Repurchase of Common Stock	-69.37	-	-	-	-
Common Dividends Paid	-87.43	-19.42	-16.84	-	-8.06
Other Financing Activities	-0.06	-	-	-	-
Financing Cash Flow	-186.29	89.75	195.83	9.52	40.4
Foreign Exchange Rate Adjustments	0.03	0.21	-0.05	0	-0.4
Net Cash Flow	-133.03	215.33	92.05	-11.37	4.63
Free Cash Flow	145.19	126.13	-102.03	-19.7	-34.87
Free Cash Flow Growth	15.11%	-	-	-	-
Free Cash Flow Margin	18.65%	16.85%	-16.32%	-6.51%	-14.51%
Free Cash Flow Per Share	4.74	4.31	-3.60	-0.76	-1.44
Cash Interest Paid	1.25	3.44	1.42	0.31	0.83
Cash Income Tax Paid	40.04	47.43	15.49	5.13	21.14
Levered Free Cash Flow	91.4	88.6	-139.37	-32.65	-42.65
Unlevered Free Cash Flow	93.26	91.96	-138.05	-31.74	-41.68
Change in Working Capital	-16.51	-31.28	2.25	-12.7	4.55

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.